deltatrials
Active Not Recruiting PHASE2 INTERVENTIONAL 2-arm NCT03782636

Interleukin-2 Therapy of Autoimmunity in Diabetes (ITAD) (ITAD)

Sponsor: Centre for Statistics in Medicine, Oxford

Conditions Type1 Diabetes
Interventions Aldesleukin Placebo
Updated 13 times since 2019 Last updated: Sep 29, 2025 Started: Jan 28, 2019 Primary completion: Feb 16, 2023 Completion: Sep 30, 2026
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03782636, this PHASE2 trial focuses on Type1 Diabetes and remains ongoing. Sponsored by Centre for Statistics in Medicine, Oxford, it has been updated 13 times since 2019, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Jan 2019 – ~Oct 2019 · 9 months · monthly snapshot~Oct 2019 – ~Feb 2020 · 4 months · monthly snapshot~Feb 2020 – ~Jan 2021 · 11 months · monthly snapshot~Jan 2021 – ~Feb 2021 · 31 days · monthly snapshot~Feb 2021 – ~Jan 2022 · 11 months · monthly snapshot~Jan 2022 – ~Feb 2023 · 13 months · monthly snapshot~Feb 2023 – ~Nov 2023 · 9 months · monthly snapshot~Nov 2023 – ~Jul 2024 · 8 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Feb 2025 · 5 months · monthly snapshot~Feb 2025 – ~Sep 2025 · 7 months · monthly snapshot~Sep 2025 – ~Nov 2025 · 2 months · monthly snapshot~Nov 2025 – present · 8 months · monthly snapshot

Change History

13 versions recorded

  1. Nov 2025 — Present [monthly]

    Active Not Recruiting PHASE2

    Status: Unknown → Active Not Recruiting

  2. Sep 2025 — Nov 2025 [monthly]

    Unknown PHASE2

  3. Feb 2025 — Sep 2025 [monthly]

    Unknown PHASE2

  4. Sep 2024 — Feb 2025 [monthly]

    Unknown PHASE2

  5. Jul 2024 — Sep 2024 [monthly]

    Unknown PHASE2

    Status: Unknown Status → Unknown

▶ Show 8 earlier versions

  1. Nov 2023 — Jul 2024 [monthly]

    Unknown Status PHASE2

    Status: Active Not Recruiting → Unknown Status

  2. Feb 2023 — Nov 2023 [monthly]

    Active Not Recruiting PHASE2

  3. Jan 2022 — Feb 2023 [monthly]

    Active Not Recruiting PHASE2

    Status: Recruiting → Active Not Recruiting

  4. Feb 2021 — Jan 2022 [monthly]

    Recruiting PHASE2

  5. Jan 2021 — Feb 2021 [monthly]

    Recruiting PHASE2

  6. Feb 2020 — Jan 2021 [monthly]

    Recruiting PHASE2

  7. Oct 2019 — Feb 2020 [monthly]

    Recruiting PHASE2

    Status: Not Yet Recruiting → Recruiting

  8. Jan 2019 — Oct 2019 [monthly]

    Not Yet Recruiting PHASE2

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Centre for Statistics in Medicine, Oxford
  • Juvenile Diabetes Research Foundation
  • Oxford Clinical Trials Research Unit (OCTRU)
  • University of Oxford
  • Wellcome Trust
Data source: University of Oxford

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations